Viviana IZZO | Projects
Viviana IZZO Projects
1 Funded projects
Filter
Dapagliflozin is a selective inhibitor of sodiumâ¿¿glucose cotransporter 2 (SGLT2), which blocks glucose resorption in the proximal tubule of the kidney and promotes glycosuria. It is indicated in adults for the treatment of inadequately controlled type 2 diabetes mellitus (T2DM) in combination with diet and exercise. Several studies have shown cardioprotective benefits of dapagliflozin,contributing
| Department | Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED | |
| Principal Investigator | IZZO Viviana (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 3.242,90 euro | |
| Project duration | 25 November 2024 - 25 November 2028 | |
| Detail |
Data source U-GOV dal 1 Gennaio 2013
